Piper Sandler analyst David Westenberg raised the firm’s price target on Illumina (ILMN) to $190 from $185 following quarterly results. The ...
Barclays downgraded Illumina (ILMN) to Underweight from Equal Weight with a price target of $100, down from $130. The firm sees greater risk to ...